Skip to content
10-Q

Quarterly Report

CUMBERLAND PHARMACEUTICALS INC CPIX

0001087294-25-000020

← back to feed
Filed
Nov 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 5, 2025 14.96M sh
Shares Diluted Q3 2025 · Sep 30, 2025 14.96M sh
Shares Diluted Q3 2025 · Sep 30, 2025 14.95M sh
Shares Diluted Q3 2025 · Sep 30, 2024 14.05M sh
Shares Diluted Q3 2025 · Sep 30, 2024 14.09M sh
Stock Repurchased Q3 2025 · Sep 30, 2025 $263.48K
Stock Repurchased Q3 2025 · Sep 30, 2024 $480.67K
Capex Q3 2025 · Sep 30, 2025 $97.9K
Capex Q3 2025 · Sep 30, 2024 $64.18K
Operating Cash Flow Q3 2025 · Sep 30, 2025 $4.93M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$2.52M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $15.2M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $17.96M
Stockholders Equity Q3 2025 · Sep 30, 2025 $26.12M
Stockholders Equity Q3 2025 · Dec 31, 2024 $22.85M
Current Liabilities Q3 2025 · Sep 30, 2025 $24.31M
Current Liabilities Q3 2025 · Dec 31, 2024 $31.62M
Total Liabilities Q3 2025 · Sep 30, 2025 $40.1M
Total Liabilities Q3 2025 · Dec 31, 2024 $53.04M
Current Assets Q3 2025 · Sep 30, 2025 $29.94M
Current Assets Q3 2025 · Dec 31, 2024 $36.45M
Total Assets Q3 2025 · Sep 30, 2025 $65.9M
Total Assets Q3 2025 · Dec 31, 2024 $75.58M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.13
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.10
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.11
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.32
Eps Basic Q3 2025 · Sep 30, 2025 −$0.13
Eps Basic Q3 2025 · Sep 30, 2025 −$0.10
Eps Basic Q3 2025 · Sep 30, 2024 −$0.11
Eps Basic Q3 2025 · Sep 30, 2024 −$0.32
Sga Expense Q3 2025 · Sep 30, 2025 $2.57M
Sga Expense Q3 2025 · Sep 30, 2025 $7.91M
Sga Expense Q3 2025 · Sep 30, 2024 $2.68M
Sga Expense Q3 2025 · Sep 30, 2024 $7.8M
Rd Expense Q3 2025 · Sep 30, 2025 $1.25M
Rd Expense Q3 2025 · Sep 30, 2025 $4.02M
Rd Expense Q3 2025 · Sep 30, 2024 $1.31M
Rd Expense Q3 2025 · Sep 30, 2024 $3.52M
Net Income Q3 2025 · Sep 30, 2025 −$1.94M
Net Income Q3 2025 · Sep 30, 2025 −$1.42M
Net Income Q3 2025 · Sep 30, 2024 −$1.54M
Net Income Q3 2025 · Sep 30, 2024 −$4.58M
Operating Income Q3 2025 · Sep 30, 2025 −$1.97M
Operating Income Q3 2025 · Sep 30, 2025 −$1.42M
Operating Income Q3 2025 · Sep 30, 2024 −$1.69M
Operating Income Q3 2025 · Sep 30, 2024 −$4.59M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $988.76K
Cost Of Revenue Q3 2025 · Sep 30, 2025 $4.43M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $1.32M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $4.61M
Revenue Q3 2025 · Sep 30, 2025 $8.29M
Revenue Q3 2025 · Sep 30, 2025 $30.84M
Revenue Q3 2025 · Sep 30, 2024 $9.09M
Revenue Q3 2025 · Sep 30, 2024 $27.43M